Business
Annexin's rights issue 100 percent subscribed, top guarantee commitments included, and resolution on directed issue to guarantors
Annexin's rights issue 100 percent subscribed, top guarantee commitments included, and resolution on directed issue to
About this update from Annexin Pharmaceuticals Ab
[{"type":"text","content":"NOT INTENDED FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, RUSSIA, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OR INVITATION TO ACQUIRE OR SUBSCRIBE FOR ANY SECURITIES IN ANNEXIN PHARMACEUTICALS AB IN ANY JURISDICTION. SEE THE SECTION “IMPORTANT INFORMATION” BELOW.The subscription period in Annexin Pharmaceuticals AB (publ)'s (\"Annexin\" or the \"Company\") new share issue with preferential rights for the Company's existing shareholders (the \"Rights Issue\"), resolved by the board on 6 February 2025 and approved by an Extraordinary General Meeting on 25 February 2025, ended on 24 March 2025. In the Rights Issue, a total of 131,753,749 shares were subscribed for, corresponding to 79 percent, with and without subscription rights. A total of 34,802,096 shares, corresponding to 21 percent, were subscribed for via the top guarantee commitments agreed on together with an external investor consortium. Through the Rights Issue, the Company receives approximately SEK 50 million, before issue costs. Furthermore, the board has resolved, based on the authorization from the Annual General Meeting on 2 May 2024, on a directed share issue of 6,000,000 shares to guarantors in the Rights Issue as compensation for their guarantee commitments (the \"Directed Share Issue\"). The subscription price in the Directed Share Issue is set at SEK 0.30 per share.Outcome of the Rights IssueThe subscription period in the Rights Issue ended on March 24, 2025. The Rights Issue was subscribed to approximately 77.4 percent with subscription rights and to approximately 1.7 percent without subscription rights. In total, the Rights Issue, with and without subscription rights, was thus subscribed to 79.1 percent. A total of 20.9 percent was subscribed via the top guarantee commitments agreed with an external investor consortium with a long-term investment horizon. The Rights Issue has thus been 100 percent subscribed and Annexin will receive approximately SEK 50,0 million before issue costs.Notification of allotment of shares subscribed for without subscription rights is expected to be sent to those who have been allotted ...